Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Non-GLP study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Report date:
1976

Materials and methods

Test guidelineopen allclose all
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Qualifier:
equivalent or similar to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
4-methylpyridine
EC Number:
203-626-4
EC Name:
4-methylpyridine
Cas Number:
108-89-4
Molecular formula:
C6H7N
IUPAC Name:
4-methylpyridine
Test material form:
gas under pressure: refrigerated liquefied gas
Details on test material:
- Name of test material: 4-Methylpyridine

Test animals

Species:
rat
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: Young animals, not previously used for testing purposes
- Weight at study initiation: 200-300 g
- Fasting period before study: 24 hours

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
Due to the small amount of the test material required it was measured and mixed with propylene glycol prior to being intubated via a syringe and
stainless steel catheter.
Doses:
125, 250, 500, 630, 800, 1000, 2000 mg/kg bw/day
No. of animals per sex per dose:
5 rats per sex per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: no
- Other examinations performed: clinical signs

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LD50
Effect level:
470 mg/kg bw
Based on:
test mat.
95% CL:
300 - 720
Sex:
female
Dose descriptor:
LD50
Effect level:
460 mg/kg bw
Based on:
test mat.
95% CL:
300 - 720
Clinical signs:
other: Lethargy and unkempt coats were noted in the animals dosed at levels ranging from 125 mg/kg bw - 500 mg/kg bw. Ocular hemorrhage accompanied lethargy and unkempt coats at 630 mg/kg bw and 800 mg/kg bw. Comas preceded death in the animals which succumbed.

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
LD50 values for males and females were determined at 470 mg/kg bw and 460 mg/kg bw, respectively.